Literature DB >> 27673458

EpiPen price hike comes under scrutiny.

Rita Rubin.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27673458     DOI： 10.1016/S0140-6736(16)31708-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Tertiary patenting on drug-device combination products in the United States.

Authors:  Reed F Beall; Aaron S Kesselheim
Journal:  Nat Biotechnol       Date:  2018-02-06       Impact factor: 54.908

Review 2.  Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.

Authors:  Benjamin T Prince; Irene Mikhail; David R Stukus
Journal:  J Asthma Allergy       Date:  2018-06-20

3.  Changes in Drug List Prices and Amounts Paid by Patients and Insurers.

Authors:  Eric J Yang; Emilio Galan; Robert Thombley; Andrew Lin; Jaeyun Seo; Chien-Wen Tseng; Jack S Resneck; Peter B Bach; R Adams Dudley
Journal:  JAMA Netw Open       Date:  2020-12-01

4.  Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis.

Authors:  Marcus Shaker; Matthew Greenhawt
Journal:  JAMA Netw Open       Date:  2018-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.